相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Elongation Factor-2, a Th1 Stimulatory Protein of Leishmania donovani, Generates Strong IFN-γ and IL-12 Response in Cured Leishmania-Infected Patients/Hamsters and Protects Hamsters against Leishmania Challenge
Pramod K. Kushawaha et al.
JOURNAL OF IMMUNOLOGY (2011)
Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis
Sijumon Kunjachan et al.
JOURNAL OF MICROENCAPSULATION (2011)
Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani
Jaspreet Kaur et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Triggering of Suicidal Erythrocyte Death by Amphotericin B
Hasan Mahmud et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2009)
Immunization with the DNA-Encoding N-Terminal Domain of Proteophosphoglycan of Leishmania donovani Generates Th1-Type Immunoprotective Response against Experimental Visceral Leishmaniasis
Mukesh Samant et al.
JOURNAL OF IMMUNOLOGY (2009)
Effect of cationic lipid composition on properties of oligonucleotide/emulsion complexes: Physico-chemical and release studies
Erico Martini et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Antileishmanial activity of nano-amphotericin B deoxycholate
Krishna Das Manandhar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Design and production of nanoparticles formulated from nano-emulsion templates - A review
Nicolas Anton et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection
Jayati Mookerjee Basu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
Francois Chappuis et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis
Swati Gupta et al.
JOURNAL OF DRUG TARGETING (2007)
Leishmania donovani:: Identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis
R Garg et al.
VACCINE (2006)
Polymeric nanocapsules containing an antiseptic agent obtained by controlled nanoprecipitation onto water-in-oil miniemulsion droplets
U Paiphansiri et al.
MACROMOLECULAR BIOSCIENCE (2006)
Reorganization of lipid nanocapsules at air-water interface I. Kinetics of surface film formation
I Minkov et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2005)
Reorganization of lipid nanocapsules at air-water interface - Part 2. Properties of the formed surface film
I Minkov et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2005)
Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation:: Evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis
R Basu et al.
JOURNAL OF IMMUNOLOGY (2005)
Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models
A Dube et al.
PARASITOLOGY RESEARCH (2005)
Design of a phytosphingosine-containing, positively-charged nanoemulsion as a colloidal carrier system for dermal application of ceramides
E Yilmaz et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Receptor-mediated stimulatory effect of oligochitosan in macrophages
J Feng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Potential role of nuclear factor-kappaB in the induction of nitric oxide nd tumor necrosis factor-alpha by oligochitosan in macrophages
ZJ Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Cloning of S-adenosyl-L-Methionine:: C-24-Δ-sterol-methyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-resistant promastigotes
M Pourshafie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis
JA Sanchez-Brunete et al.
JOURNAL OF DRUG TARGETING (2004)
Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages
C Porporatto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Production and characterization of O/W emulsions containing cationic droplets stabilized by lecithin-chitosan membranes
S Ogawa et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2003)
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study
J Vandervoort et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Overview of the lipid formulations of amphotericin B
B Dupont
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
A new lipid emulsion formulation with high antimicrobial efficacy using chitosan
M Jumaa et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2002)
Topical formulations and wound healing applications of chitosan
H Ueno et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Leishmaniasis: Current status of vaccine development
E Handman
CLINICAL MICROBIOLOGY REVIEWS (2001)
Microemulsion-based media as novel drug delivery systems
MJ Lawrence et al.
ADVANCED DRUG DELIVERY REVIEWS (2000)
Synergistic cooperation between water-soluble chitosan oligomers and interferon-γ for induction of nitric oxide synthesis and tumoricidal activity in murine peritoneal macrophages
WG Seo et al.
CANCER LETTERS (2000)
Influence of continuous phase viscosity on emulsification by ultrasound
O Behrend et al.
ULTRASONICS SONOCHEMISTRY (2000)
A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis
V Yardley et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)